Ndu Adora's Insider Trades & SAST Disclosures
Ndu Adora's most recent trade in Acadia Pharmaceuticals Inc was a trade of 4,381 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ndu Adora.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2024 | 4,381 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2024 | 4,381 | 15,414 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 15,959 | 15,959 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,387 | 9,387 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 6,652 | 11,033 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 6,652 | 0 | - | - | Restricted Stock Units | |
| DBV Technologies - ADR | Ndu Adora | Director | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 06 Feb 2024 | 1,825 | 1,825 (0%) | 0% | 0.9 | 1,624 | Ordinary Shares |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 11,045 | 11,045 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 6,652 | 6,652 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 14,077 | 14,077 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 8,762 | 8,762 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges